TrialLancet (London, England)2011

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

John Burn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.